M^T Bank Corporation »

Apellis Pharmaceuticals shares owned by M^T Bank Corporation

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by M^T Bank Corporation from 13F filings

Historical chart of M^T Bank Corporation investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by M^T Bank Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by M^T Bank Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $280k 4.7k 59.86

More positions owned by M^T Bank Corporation

Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Rus 1000 Val Etf (IWD)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr S&p 500 Grwt Etf (IVW)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Johnson & Johnson (JNJ)

View all positions for M^T Bank Corporation

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
Jennison Associates
Octagon Capital Advisors
Jpmorgan Chase & Co
T. Rowe Price Associates
Assenagon Asset Management
Logos Global Management
Boxer Capital
Artal Group
Citadel Advisors
Caption Management
Norges Bank Investment Management

View all funds holding Apellis Pharmaceuticals